Inventor

CAMPBELL JOHN EMMERSON

US37 patents

⚠️ This page may combine multiple inventors who share the name “CAMPBELL JOHN EMMERSON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CAMPBELL JOHN EMMERSON

EPIZYME INC

Substituted benzene compounds

Substituted benzene compounds

Substituted 6,5-fused bicyclic heteroaryl compounds

Substituted benzene compounds

Substituted benzene compounds

1,4-pyridone bicycic heteroaryl compounds

Substituted benzene compounds

Substituted 6,5-fused bicyclic heteroaryl compounds

1,4-pyridone bicyclic heteroaryl compounds

Substituted 6,5-fused bicyclic heteroaryl compounds

Substituted 6, 5-fused bicyclic heteroaryl compounds

Substituted benzene compounds

Substituted benzene compounds

Substituted 6,5-fused bicyclic heteroaryl compounds

Substituted benzene compounds

Combination therapies with EHMT2 inhibitors

MYST family histone acetyltransferase inhibitors

SUNOVION PHARMACEUTICALS INC

Substituted [1,2,4]triazolo[1,5-a]pyridines as PDE-10 inhibitors

Multicyclic compounds and methods of use thereof

Multicyclic compounds and methods of use thereof

Multicyclic compounds and methods of use thereof

Heteroaryl compounds and methods of use thereof

Heteroaryl compounds and methods of use thereof

Substituted quinoxalines as PDE-10 inhibitors

Heteroaryl compounds and methods of use thereof

Substituted pyrazolo[1,5-a]pyridines as PDE-10 inhibitors

Substituted quinolines as PDE-10 inhibitors

Heteroaryl compounds and methods of use thereof

Substituted imidazo[1,2-a]pyridines as PDE-10 inhibitors

Substituted [1,2,4]triazolo[1,5-a]pyrazines as phosphodiesterase inhibitors

CAMPBELL JOHN EMMERSON

Substituted quinoxalines and quinoxalinones as PDE-10 inhibitors

[1,2,4] triazol [1,5-a] pyrazines useful as inhibitors of phosphodiesterases

BLUEPRINT MEDICINES CORP

EGFR inhibitors

EGFR inhibitors

SUNOVION PHARAMACEUTICALS INC

Substituted cyclopropanes as PDE-10 inhibitors

Substituted [1,2,4]triazolo[1,5-a]pyrazines as phosphodiesterase inhibitors

SHAO LIMING

Multicyclic compounds and methods of use thereof